CXCL1 supplementation on iPSC-Derived Midbrain Neurons

Research Community
Research Community

ASAP supports three programs and serves as a member of multiple consortia to advance research for the benefit of the global Parkinson’s disease community.
Explore
Highlights
Highlights

ASAP shares the impact that our initiative, network, and supported programs have had on providing new insights into Parkinson’s disease. Discover news, interviews, awards, and annual impact.
Explore
Open Science
Open Science

ASAP is dedicated to facilitating a research environment where meaningful collaboration, research-enabling resources, and data sharing provides the answers we need to understand, diagnose, and treat Parkinson’s disease. Discover our open science philosophy.
Explore
Tools & Resources
Tools & Resources

ASAP is committed to developing and openly sharing research outputs, including data, code, protocols, and key lab materials, to help the scientific community build upon existing work.
Explore

Description

This protocol aims to investigate the effects of varying concentrations of recombinant human CXCL1 on primary midbrain neuronal cultures derived from induced pluripotent stem cells (iPSCs) using conditioned media from ATP13A2WT astrocytes.

Identifier (DOI)

10.17504/protocols.io.dm6gp7681gzp/v1

Discovery Team

Team Vangheluwe

Program

Collaborative Research Network

Theme

PD Functional Genomics

Meet the Authors

Elena Coccia

External Collaborator

CXCL1 supplementation on iPSC-Derived Midbrain Neurons

Output Details

Meet the Authors

Elena Coccia

Related Research

ATP13A2 Loss of Function-Driven Polyamine Dysregulation Induces SAM Depletion and Epigenetic Astrocyte Toxicity

Bulk RNA-seq Protocol for Astrocytes

Bisulfite-seq for Astrocytes